Gastrectomía vertical como técnica quirúrgica en cirugía bariátricaAnálisis de resultados de seguridad y efectividad

  1. Joseba Castro Vázquez 1
  2. Fátima Saravia Barahona 1
  3. Carlos Loureiro González 1
  4. Saioa Leturio Fernández 1
  5. Marta García Fernández 1
  6. Ana Moro Delgado 1
  7. Julen Barrenetxea Asua 1
  8. Javier Ortiz Lacorzana 1
  9. Ismael Díez del Val 1
  1. 1 Servicio de Cirugía General y Aparato Digestivo, Hospital Universitario Basurto, Bilbao, Vizcaya, España
Journal:
Cirugía española: Organo oficial de la Asociación Española de Cirujanos

ISSN: 0009-739X

Year of publication: 2022

Volume: 100

Issue: 2

Pages: 88-94

Type: Book review

DOI: 10.1016/J.CIRESP.2020.11.009 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Cirugía española: Organo oficial de la Asociación Española de Cirujanos

Abstract

Introduction The aim of this study is to evaluate the safety and effectiveness results of sleeve gastrectomy as a bariatric technique. Methods Observational follow-up study of a cohort of patients who underwent sleeve gastrectomy in our center between 2008 and 2017. A total of 223 patients were included: 166 as a primary technique (group 1) and 57 as a hypothetical first stage (group 2). Results In group 1, the postoperative morbidity is 12.6%, with a fistula rate of 4.2%; 5.4% required reoperation and mortality was 0.6%. In group 2, postoperative morbidity is 14%, with a fistula rate of 5.3%; 10.5% required reoperation and mortality was 5.3%. In group 1, 79.6% and 62.5% of patients at 2 and 5 years respectively managed to achieve a % EBMIL>50%. In group 2, the second stage was completed only in 8 patients (14.0%). Of the patients who did not complete the second stage, 32.2% and 5.9% achieved a % EEBMIL>100% at 2 and 5 years. Analyzing those who completed the second stage, the mean EEBMIL% was 90.5% and 93.4% at 2 and 5 years. Conclusions Sleeve gastrectomy is a safe technique in patients with BMI<45 and effective in terms of weight loss in the short-medium term. In patients with BMI>55, a preoperative optimization aimed at reducing morbidity and mortality is necessary, as well as adequately planning the second stage, without which it is clearly insufficient.